4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-000787
Pres. Research & Development gave up 5,345 shares (to pay taxes)
- Pres. Research & Development acquired 17,272 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Young David Pres. Research & Development | 2025-04-01 | Option exercise | +17,272 | 222,677 | D | ||
| Young David Pres. Research & Development | 2025-04-01 | Shares withheld for taxes | −5,345 | $0.41 | $2,202 | 217,332 | D |
Loading xslF345X05/form4.xml…